|
SE367181B
(https=)
*
|
1969-05-14 |
1974-05-20 |
Takeda Chemical Industries Ltd |
|
|
US3644479A
(en)
*
|
1970-02-09 |
1972-02-22 |
Bristol Myers Co |
1-indancarboxylic acids and derivatives
|
|
US3663627A
(en)
*
|
1970-06-01 |
1972-05-16 |
Bristol Myers Co |
1-indanmethanols
|
|
CH585687A5
(https=)
*
|
1972-08-24 |
1977-03-15 |
Ciba Geigy Ag |
|
|
DK464274A
(https=)
*
|
1973-09-11 |
1975-05-12 |
Sandoz Ag |
|
|
FR2359135A1
(fr)
*
|
1976-07-22 |
1978-02-17 |
Hexachimie |
Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique
|
|
JPS6055071B2
(ja)
*
|
1982-04-16 |
1985-12-03 |
四国化成工業株式会社 |
イミダゾリル琥珀酸化合物および該化合物を用いるエポキシ樹脂硬化方法
|
|
JPS60105645A
(ja)
*
|
1983-11-12 |
1985-06-11 |
Yasumitsu Tamura |
アリ−ルコハク酸エステルの製造法
|
|
US4933398A
(en)
*
|
1987-07-01 |
1990-06-12 |
Ciba-Geigy Corporation |
Photosensitive epoxy resins and use thereof
|
|
DD271903A1
(de)
*
|
1988-05-17 |
1989-09-20 |
Univ Halle Wittenberg |
Verfahren zur herstellung stabiler, 2-unsubstituierter imidazol-3-oxide
|
|
AU6024998A
(en)
*
|
1997-01-15 |
1998-08-07 |
Glycomed Incorporated |
Aryl c-glycoside compounds and sulfated esters thereof
|
|
ZA98376B
(en)
*
|
1997-01-23 |
1998-07-23 |
Hoffmann La Roche |
Sulfamide-metalloprotease inhibitors
|
|
US5804581A
(en)
*
|
1997-05-15 |
1998-09-08 |
Bayer Corporation |
Inhibition of matrix metalloproteases by substituted phenalkyl compounds
|
|
US6130220A
(en)
*
|
1997-10-16 |
2000-10-10 |
Syntex (Usa) Inc. |
Sulfamide-metalloprotease inhibitors
|
|
US20010039287A1
(en)
*
|
1997-11-14 |
2001-11-08 |
Thomas E Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
US20010014688A1
(en)
*
|
1997-11-14 |
2001-08-16 |
Thomas E. Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
JP2002508345A
(ja)
*
|
1997-12-17 |
2002-03-19 |
カイロテック・テクノロジー・リミテッド |
不斉水素化
|
|
EP0952148B1
(en)
*
|
1998-04-10 |
2004-05-12 |
Pfizer Products Inc. |
Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
|
|
PA8469501A1
(es)
*
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
UA71586C2
(en)
*
|
1998-12-04 |
2004-12-15 |
Smithkline Beecham Corp |
A vitronectin receptor antagonist
|
|
HRP20010660A2
(en)
*
|
1999-02-08 |
2005-02-28 |
G.D. Searle & Co |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
CN1342146A
(zh)
*
|
1999-03-18 |
2002-03-27 |
塞尔基因公司 |
取代的1－氧代－和1,3－二氧代异吲哚啉及其在用于减少炎性细胞因子含量的药物组合物中的用途
|
|
JP2000271485A
(ja)
*
|
1999-03-24 |
2000-10-03 |
Kazuhiko Saigo |
オレフィン類のビスアルコキシカルボニル化触媒、及びコハク酸エステル誘導体の製造法
|
|
EP1165500A1
(en)
*
|
1999-04-02 |
2002-01-02 |
Du Pont Pharmaceuticals Company |
Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
|
|
PT1181286E
(pt)
*
|
1999-05-28 |
2004-02-27 |
Pfizer Prod Inc |
Hidroxamidas de acido 3-(arilsulfonilamino)-tetrahidropirano-3-carboxilico
|
|
HN2000000052A
(es)
*
|
1999-05-28 |
2001-02-02 |
Pfizer Prod Inc |
Hidroxiamidas de acidos 3- (arilsulfonilamino)- tetrahidrofuran-3-carboxilicos.
|
|
US6387901B1
(en)
*
|
1999-07-06 |
2002-05-14 |
Pfizer Inc |
Alkyne containing metalloproteinase inhibitors
|
|
GB9916562D0
(en)
*
|
1999-07-14 |
1999-09-15 |
Pharmacia & Upjohn Spa |
3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora
|
|
US20010049449A1
(en)
*
|
1999-12-23 |
2001-12-06 |
Becker Daniel P. |
Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as MMP inhibitors
|
|
US6458822B2
(en)
*
|
2000-03-13 |
2002-10-01 |
Pfizer Inc. |
2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
|
|
CA2452391A1
(en)
*
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
AU2003290120A1
(en)
*
|
2002-11-19 |
2004-06-15 |
Galderma Research & Development, S.N.C. |
Biaromatic compounds which activate PPAR-Gama type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
|
CA2558585C
(en)
*
|
2004-02-27 |
2010-10-12 |
Amgen Inc. |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
|